Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Air Pollution and Inhaled Corticosteroids in COPD
NCT06552364Phase 4Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by University of British Columbia. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06552364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06552364.